Children with classic congenital adrenal hyperplasia have elevated serum leptin concentrations and insulin

Evangelia Charmandari1, Martina Weise, Stefan R Bornstein

  • 1Pediatric and Reproductive Endocrinology Branch, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20892, USA. charmane@mail.nih.gov

Insights

Children with classic congenital adrenal hyperplasia (CAH) exhibit elevated leptin and insulin levels, alongside insulin resistance. These findings are linked to adrenal dysfunction and treatment, potentially impacting androgen production and metabolic health.

Area of Science:

  • Endocrinology
  • Pediatrics
  • Metabolic Disorders

Background:

  • Leptin, secreted by adipose tissue, regulates energy homeostasis.
  • Congenital adrenal hyperplasia (CAH) involves adrenal dysfunction, affecting hormone secretion and potentially influencing metabolic parameters.
  • Adrenomedullary function and hormonal secretion are implicated in leptin regulation.

Purpose of the Study:

  • To investigate leptin secretion in children with classic CAH.
  • To correlate leptin levels with adrenomedullary function, insulin, and androgen secretion in these patients.
  • To understand the impact of CAH on metabolic regulation.

Main Methods:

  • Studied 18 children with classic CAH and 28 age- and BMI-matched controls.
  • Measured serum leptin, plasma epinephrine and free metanephrine, fasting serum insulin, and testosterone.
  • Assessed insulin resistance using the homeostasis model assessment (HOMA) method.

Main Results:

  • Children with CAH showed significantly higher serum leptin concentrations, even after BMI correction.
  • Patients had lower epinephrine and free metanephrine, but higher insulin and testosterone levels compared to controls.
  • Insulin resistance was significantly greater in children with CAH; leptin negatively correlated with epinephrine and free metanephrine.

Conclusions:

  • Classic CAH is associated with elevated leptin and insulin, and increased insulin resistance, likely due to adrenomedullary hypofunction and glucocorticoid therapy.
  • These hormonal imbalances may exacerbate androgen production and reduce glucocorticoid efficacy.
  • Findings suggest a potential contribution to the development of polycystic ovary syndrome and metabolic syndrome in CAH patients.

Related Concept Videos

Adrenal Gland Disorders01:27

Adrenal Gland Disorders

Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Cushing Syndrome II: Pathophysiology01:19

Cushing Syndrome II: Pathophysiology

Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...